11 min read
Keypoint Newsletter- December 2022
Welcome to the Keypoint Newsletter, bringing you all the latest news & views from Keystone Symposia!
Featuring...
The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.
Clement Adebamowo, B.M., Ch.B., Hons, Sc.D., M.D., Ph.D.
Karen Adelman, Ph.D.
Zoltan Arany, M.D., Ph.D.
Yasmine Belkaid, Ph.D.
Patricia C. B. Beltrão-Braga, Ph.D.
Esther Breij, Ph.D.
Lei Cheng, Ph.D.
Jonathan D. Chesnut, Ph.D.
Roger D. Cone, Ph.D.
Thomas Conlon, Ph.D.
Chief Scientific Officer
Michelson Philanthropies
Kizzmekia S. Corbett-Helaire, Ph.D.
Assistant Professor of Immunology and Infectious Diseases
Harvard T.H. Chan School of Public Health
Carolyn B. Coyne, Ph.D.
Professor
Duke University
Ana Maria Cuervo, M.D., Ph.D.
Robertus de Bruin, Ph.D.
Weiwen Deng, Ph.D.
Principal Scientist
Amgen Inc
Philippe Denoel, Ph.D.
Head of External R&D, Vaccines
GSK
Suzanne Devkota, Ph.D.
Anwesha Dey, Ph.D.
Aris N. Economides, Ph.D.
Vice President
Regeneron Pharmaceuticals, Inc.
Sandra J. Engle, Ph.D.
Executive Director
Biogen, Inc.
Stacey D. Finley, Ph.D.
Nicole A. and Thuan Q. Pham Professor
University of Southern California
Kelly A. Frazer, Ph.D.
Dmitry I. Gabrilovich, M.D., Ph.D.
Jason E. Gestwicki, Ph.D.
Professor
University of California, San Francisco
Lora K. Heisler, Ph.D.
Robert J. Hofmeister, Ph.D.
Michael J. Holtzman, M.D.
Stefan Irion, M.D.
Aron B. Jaffe, Ph.D.
SVP, Head of Bleeding Edge
Curie.Bio
Elliott Klein, Ph.D.
Senior Research Fellow
Boehringer Ingelheim Pharmaceuticals Inc.
Katherine W. Klinger, Ph.D.
Jean K. Lim, Ph.D.
Associate Professor
Icahn School of Medicine at Mount Sinai
Jenniffer M. Maroa, Ph.D.
Senior Program Officer
Bill & Melinda Gates Foundation
Patrick Mayes, Ph.D.
Executive Director
Incyte Research Institute
Laura F. Michael, Ph.D.
Valerie Mizrahi, Ph.D.
Director
University of Cape Town
Lily Y. Moy, Ph.D.
Director, Pharmacology
Merck & Co.
James Mu, Ph.D.
Anne N. Murphy, Ph.D.
Vice President
Cytokinetics, Inc.
Shruti Naik, Ph.D.
Associate Professor
Icahn School of Medicine at Mount Sinai
Lee A. Niswander, Ph.D.
Professor and Chair
University of Colorado Boulder
Manu O. Platt, Ph.D.
Timothy Radstake, M.D., Ph.D.
Laszlo Radvanyi, Ph.D.
Professor
University of Toronto
Sridhar Ramaswamy, M.D.
Venture Partner & Entrepreneur in Residence
Google Ventures
Richard M. Ransohoff, M.D.
Venture Partner
Third Rock Ventures
Rino Rappuoli, Ph.D.
Scientific Director
Fondazione Biotecnopolo di Siena
Christopher J. Rhodes, Ph.D.
Ann-Marie T. Richard, Ph.D.
Director, Patient Engagement
Pfizer
Frank Rigo, Ph.D.
Senior Vice President
Ionis Pharmaceuticals
Mark Rolfe, Ph.D.
Senior Vice President
Bristol Myers Squibb
Pamela C. Ronald, Ph.D.
Distinguished Professor
University of California, Davis
Carla V. Rothlin, Ph.D.
Professor
Yale University
Deepak Sampath, Ph.D.
Vice President, Head of Research
Ultragenyx
Markus Schirle, Ph.D.
Executive Director
Novartis Biomedical Research
Boris Striepen, Ph.D.
Paul K.H. Tam, Ch.M.
Cormac Taylor, Ph.D.
Professor of Cellular Physiology
University College Dublin
Patrick Thibodeau, Ph.D.
VP, Basic Science Research
Cystic Fibrosis Foundation
Cornelia Liu Trimble, M.D.
Professor
Johns Hopkins University School of Medicine
Edward van der Horst, Ph.D.
Chief Scientific Officer
Sensei Biotherapeutics
Fred Van Goor, Ph.D.
Principal Research Fellow
Vertex Pharmaceuticals Incorporated
Elizabeth Villa, Ph.D.
Associate Professor
University of California, San Diego
Amy J. Wagers, Ph.D.
Professor
Harvard University
Stephanie Wengert Watts, Ph.D.
Carsten Wiethe, Ph.D.
VP Marketing & Scientific Applications
BioLegend
Mary E. Wilson, M.D.
Professor
University of Iowa and the Iowa City VA Medical Center
Dennis M. Zaller, Ph.D.
Partner, Immunology
Curie.Bio
Arturo Zychlinsky, Ph.D.
Director
Max Planck Institute for Infection Biology
Dec 8, 2022 by Shannon Weiman
Welcome to the Keypoint Newsletter, bringing you all the latest news & views from Keystone Symposia!
Featuring...
Dec 1, 2021 by Shannon Weiman
By Ralph A. Bradshaw
What is now the Keystone Symposia on Molecular and Cellular Biology, which hosts an international...